ChemicalBook > Product Catalog >Materials Chemistry >Ligands >MOF Ligands >Duvoglustat Hydrochloride

Duvoglustat Hydrochloride

Duvoglustat Hydrochloride Suppliers list
Company Name: Henan Lavoisier Chemical Products Co. Ltd  Gold
Tel: 0371-63682289 18625781376
Email: sales@lavoisier.cn
Company Name: MedChemexpress LLC  
Tel: 021-58955995
Email: sales@medchemexpress.cn
Company Name: Shanghai Raise Chemical Technology Co.,Ltd  
Tel: 15026594951
Email: rs@raise-chem.com
Company Name: Bide Pharmatech Ltd.  
Tel: 400-164-7117 18317119277
Email: product02@bidepharm.com
Company Name: Hangzhou J&H Chemical Co., Ltd.  
Tel: 0571-87396432
Email: sales@jhechem.com

Duvoglustat Hydrochloride manufacturers

  • Ridinilazole
  • Ridinilazole pictures
  • $43.00
  • 2026-04-22
  • CAS:308362-25-6
  • Purity: 98.57%
  • Supply Ability: 10g
Duvoglustat Hydrochloride Basic information
Product Name:Duvoglustat Hydrochloride
Synonyms:2,2'-di(pyridin-4-yl)-3H,3'H-5,5'-bibenzo[d]imidazole;SMT19969;5,5'-Bi-1H-benzimidazole, 2,2'-di-4-pyridinyl-;2,2'-Di(pyridin-4-yl)-1H,1'H-5,5'-bibenzo[d]imidazole;SMT 19969,inhibit,SMT-19969,Bacterial,Ridinilazole,Inhibitor;Ridinilazole, 10 mM in DMSO
CAS:308362-25-6
MF:C24H16N6
MW:388.42
EINECS:
Product Categories:
Mol File:308362-25-6.mol
Duvoglustat Hydrochloride Structure
Duvoglustat Hydrochloride Chemical Properties
Boiling point 774.9±70.0 °C(Predicted)
density 1.372±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : ≥ 60 mg/mL (154.47 mM)
pka9.84±0.10(Predicted)
form Solid
color Light yellow to yellow
InChIInChI=1S/C24H16N6/c1-3-19-21(29-23(27-19)15-5-9-25-10-6-15)13-17(1)18-2-4-20-22(14-18)30-24(28-20)16-7-11-26-12-8-16/h1-14H,(H,27,29)(H,28,30)
InChIKeyUHQFBTAJFNVZIV-UHFFFAOYSA-N
SMILESC1(C2C=CN=CC=2)NC2=CC=C(C3=CC=C4NC(C5C=CN=CC=5)=NC4=C3)C=C2N=1
Safety Information
MSDS Information
Duvoglustat Hydrochloride Usage And Synthesis
UsesRidinilazole is a novel antibacterial with MICs range of 0.06-0.25μg/mL (MIC90=8μg/mL) against C.difficile.
in vivo

In a hamster model of CDI with a once-daily dosing regimen, Ridinilazole displays greater efficacy than Vancomycin both against non-epidemic and epidemic strains of C.difficile. Similar to the twice-daily dosing study, plasma levels of Ridinilazole are below the level of detection, whereas caecal Ridinilazole concentrations are well above the MIC, thus demonstrating the non-absorbable nature of Ridinilazole and minimal systemic exposure[1].

References[1] Vickers RJ, et al. Ridinilazole: a novel therapy for Clostridium difficile infection. Int J Antimicrob Agents. 2016 Aug;48(2):137-43. DOI:10.1016/j.ijantimicag.2016.04.026
Duvoglustat Hydrochloride Preparation Products And Raw materials
Tag:Duvoglustat Hydrochloride(308362-25-6) Related Product Information
Doxorubicin hydrochloride Rapamycin Brefeldin A Adenosine triphosphate Neomycin sulfate Streptozotocin